Active Ingredient(s): Infliximab-dyyb
FDA Approved: * April 5, 2016
Pharm Company: * CELLTRION INC
Category: Immunosuppressive

Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease.[2] It is given by slow injection into a vein, typically at six- to eight-week intervals.[2] Common side effects include infections, acute infusion reacti... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Inflectra 100 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0069-0809
Pfizer Laboratories Div Pfizer Inc

Related Brands

Drugs with the same active ingredients